BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 31102582)

  • 1. PARPs and PAR as novel pharmacological targets for the treatment of stress granule-associated disorders.
    Grimaldi G; Catara G; Palazzo L; Corteggio A; Valente C; Corda D
    Biochem Pharmacol; 2019 Sep; 167():64-75. PubMed ID: 31102582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inputs and outputs of poly(ADP-ribosyl)ation: Relevance to oxidative stress.
    Hegedűs C; Virág L
    Redox Biol; 2014; 2():978-82. PubMed ID: 25460733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADP-Ribosylation as Post-Translational Modification of Proteins: Use of Inhibitors in Cancer Control.
    Poltronieri P; Miwa M; Masutani M
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New PARP targets for cancer therapy.
    Vyas S; Chang P
    Nat Rev Cancer; 2014 Jul; 14(7):502-9. PubMed ID: 24898058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Role of ADP-Ribosyl-Acceptor Hydrolase 3 in poly(ADP-Ribose) Polymerase-1 Response to Oxidative Stress.
    Mashimo M; Moss J
    Curr Protein Pept Sci; 2016; 17(7):633-640. PubMed ID: 27090906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.
    Virág L
    Curr Vasc Pharmacol; 2005 Jul; 3(3):209-14. PubMed ID: 16026317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ADP-ribose): PARadigms and PARadoxes.
    Bürkle A; Virág L
    Mol Aspects Med; 2013 Dec; 34(6):1046-65. PubMed ID: 23290998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The poly(ADP-ribose) polymerases (PARPs): new roles in intracellular transport.
    Abd Elmageed ZY; Naura AS; Errami Y; Zerfaoui M
    Cell Signal; 2012 Jan; 24(1):1-8. PubMed ID: 21840394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of PARPs in Inflammation-and Metabolic-Related Diseases: Molecular Mechanisms and Beyond.
    Ke Y; Wang C; Zhang J; Zhong X; Wang R; Zeng X; Ba X
    Cells; 2019 Sep; 8(9):. PubMed ID: 31500199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell Cycle Resolved Measurements of Poly(ADP-Ribose) Formation and DNA Damage Signaling by Quantitative Image-Based Cytometry.
    Michelena J; Altmeyer M
    Methods Mol Biol; 2017; 1608():57-68. PubMed ID: 28695503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells.
    Mashimo M; Bu X; Aoyama K; Kato J; Ishiwata-Endo H; Stevens LA; Kasamatsu A; Wolfe LA; Toro C; Adams D; Markello T; Gahl WA; Moss J
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential and Concordant Roles for Poly(ADP-Ribose) Polymerase 1 and Poly(ADP-Ribose) in Regulating WRN and RECQL5 Activities.
    Khadka P; Hsu JK; Veith S; Tadokoro T; Shamanna RA; Mangerich A; Croteau DL; Bohr VA
    Mol Cell Biol; 2015 Dec; 35(23):3974-89. PubMed ID: 26391948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-Ribose) Polymerases in Plants and Their Human Counterparts: Parallels and Peculiarities.
    Rissel D; Peiter E
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30986964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of PARP and protein poly-ADP-ribosylation process in regulation of cell functions].
    Drel' VR; Shymans'kyĭ IO; Sybirna NO; Velykyĭ MM
    Ukr Biokhim Zh (1999); 2011; 83(6):5-34. PubMed ID: 22364016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro.
    Lin KY; Huang D; Kraus WL
    Methods Mol Biol; 2018; 1813():91-108. PubMed ID: 30097863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ADP-ribose) polymerase-1 affects vasopressin-mediated AQP2 expression in collecting duct cells of the kidney.
    Jang HJ; Park E; Jung HJ; Kwon TH
    Am J Physiol Renal Physiol; 2024 Jan; 326(1):F69-F85. PubMed ID: 37855039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological levels of poly(ADP-ribose) during the cell cycle regulate HeLa cell proliferation.
    Yamashita S; Tanaka M; Ida C; Kouyama K; Nakae S; Matsuki T; Tsuda M; Shirai T; Kamemura K; Nishi Y; Moss J; Miwa M
    Exp Cell Res; 2022 Aug; 417(1):113163. PubMed ID: 35447104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative site-specific ADP-ribosylation profiling of DNA-dependent PARPs.
    Gagné JP; Ethier C; Defoy D; Bourassa S; Langelier MF; Riccio AA; Pascal JM; Moon KM; Foster LJ; Ning Z; Figeys D; Droit A; Poirier GG
    DNA Repair (Amst); 2015 Jun; 30():68-79. PubMed ID: 25800440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs.
    Gibson BA; Kraus WL
    Nat Rev Mol Cell Biol; 2012 Jun; 13(7):411-24. PubMed ID: 22713970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PARP1-produced poly-ADP-ribose causes the PARP12 translocation to stress granules and impairment of Golgi complex functions.
    Catara G; Grimaldi G; Schembri L; Spano D; Turacchio G; Lo Monte M; Beccari AR; Valente C; Corda D
    Sci Rep; 2017 Oct; 7(1):14035. PubMed ID: 29070863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.